Clinical and Biologic Significance of <i>MYC</i> Genetic Mutations in <i>De Novo</i> Diffuse Large B-cell LymphomaZijun Y. Xu‐Monette, Ken H. Young, Qipan Deng et al.|Clinical Cancer Research|2016Cited by 66
p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor functionZijun Y. Xu‐Monette, Ken H. Young, Xiao-Xiao Wang et al.|Aging|2016Cited by 25